Wei Yin
8PUBLICATIONS
2CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Sep 23, 2024
Concentration-QTc analysis of soticlestat in healthy adults: An alternative to a thorough QT study.Wei Yin, Nobuhito Dote, Hiroyuki Fukase
|Jul 12, 2024
Phase 1 pharmacokinetic and safety study of soticlestat in participants with mild or moderate hepatic impairment or normal hepatic function.Wei Yin, Pranab Mitra, Veronique Copalu
|Mar 06, 2024
Population pharmacokinetics, enzyme occupancy, and pharmacodynamic modeling of soticlestat in patients with developmental and epileptic encephalopathies.Wei Yin, Axel Facius, Mahnaz Asgharnejad
|Dec 20, 2023
Effects of Strong Inhibition of Cytochrome P450 3A and UDP glucuronosyltransferase 1A9 and Strong Induction of Cytochrome P450 3A on the Pharmacokinetics, Safety, and Tolerability of Soticlestat: Two Drug-Drug Interaction Studies in Healthy Volunteers.Wei Yin, Cheng Dong, Annette Stevenson
|Sep 29, 2023
Investigation of the absolute bioavailability, mass balance, metabolism, and excretion of the cholesterol 24-hydroxylase inhibitor soticlestat in healthy volunteers.Wei Yin, T Eric Ballard, Sean Xiaochun Zhu
|May 22, 2023
Population pharmacokinetics, enzyme occupancy, and 24S-hydroxycholesterol modeling of soticlestat, a novel cholesterol 24-hydroxylase inhibitor, in healthy adults.Wei Yin, Axel Facius, Thomas Wagner
Pageof 2
